坎托菲茨杰拉德公司:下调Keros Therapeutics评级

证券之星
22 Jan

坎托菲茨杰拉德公司:下调keros Therapeutics(KROS.US)评级,由增持调整至中性评级。Keros Therapeutics(KROS.US)公司简介:Keros Therapeutics Inc是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。该公司的蛋白治疗候选产品KER-050正在开发中,用于治疗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10